Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Inhaled Nitric Oxide for High Amplitude Pulmonary Edema (HAPE) — Stella

Recruiting

Back to High Altitude Pulmonary Hypertension trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Tibet Fokang Hospital, Lhasa, Tibet

Key details

Sponsor

Novlead Inc.

Collaborators

Tibet Fokind Hospital

Enrollment target

~100 participants

Started

August 2023

Primary completion

December 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 65 Years

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov